Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS

  • Read more about NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
US Patent 5,462,946
Filed on 1992-03-20

A METHOD FOR DETECTION OF MYCOPLASMA

  • Read more about A METHOD FOR DETECTION OF MYCOPLASMA
US Patent 5,376,525
Filed on 1992-09-24

METHOD OF CONTROLLING CELL PROLIFERATION AND PHARMACEUTICAL COMPOSITION THEREFOF

  • Read more about METHOD OF CONTROLLING CELL PROLIFERATION AND PHARMACEUTICAL COMPOSITION THEREFOF
US Application 07/867,759
Filed on 1992-04-13

HUMAN LIVER EPITHELIAL CELL LINE AND CULTURE MEDIA THEREFOR

  • Read more about HUMAN LIVER EPITHELIAL CELL LINE AND CULTURE MEDIA THEREFOR
US Application 07/377,967
Filed on 1989-07-11

IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES

  • Read more about IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES
US Patent 5,356,806
Filed on 1992-04-13

TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF

  • Read more about TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF
US Application 07/868,408
Filed on 1992-04-14

METHOD FOR IDENTIFYING HUMANS WITH GENETIC DEFECT IN DRUG METABOLISM

  • Read more about METHOD FOR IDENTIFYING HUMANS WITH GENETIC DEFECT IN DRUG METABOLISM
US Application 07/845,507
Filed on 1992-02-27

Method of Preparing an Active Human Neutrophil Chemotactic factor Polypeptide

  • Read more about Method of Preparing an Active Human Neutrophil Chemotactic factor Polypeptide
US Patent 5,401,643
Filed on 1992-03-23

FIRST IMMORTALIZED KAPOSI'S SARCOMA CELL LINE

  • Read more about FIRST IMMORTALIZED KAPOSI'S SARCOMA CELL LINE
US Patent 5,569,602
Filed on 1993-08-20

06-SUBSTITUTED GUANINE DERIVATIVES POSSESSING 06-ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY FOR USE IN ENHANCING...

  • Read more about 06-SUBSTITUTED GUANINE DERIVATIVES POSSESSING 06-ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY FOR USE IN ENHANCING...
US Application 07/875,438
Filed on 1992-04-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1617
  • Page 1618
  • Page 1619
  • Page 1620
  • Page 1621
  • Page 1622
  • Page 1623
  • Page 1624
  • Page 1625
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health